Suchergebnisse - "Byrd, John"

PubPharm (18)

1

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

enthalten in: Leukemia research | 2022

von Goswami, S. | Chiang, C. | Zapolnik, K. | +11

2

Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia

enthalten in: Leukemia research | 2020

von Solman, I. | Blum, L. | Hoh, H. | +11

3

Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia

enthalten in: Leukemia research | 2020

von Saygin, C. | Grieselhuber, N. | Blachly, J. | +8

4

BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation

enthalten in: Leukemia research | 2015

von Tsai, Y. | Lozanski, G. | Lehman, A. | +7

5

Final results of EFC6663 : a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

enthalten in: Leukemia research | 2015

von Lanasa, M. | Andritsos, L. | Brown, J. | +16

6

Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

enthalten in: Leukemia research | 2015

von Lanasa, M. | Andritsos, L. | Brown, J. | +16

7

BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation

enthalten in: Leukemia research | 2015

von Tsai, Y. | Lozanski, G. | Lehman, A. | +7

8

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia

enthalten in: Leukemia research | 2014

von Maddocks, K. | Ruppert, A. | Browning, R. | +12

9

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia

enthalten in: Leukemia research | 2014

von Maddocks, K. | Ruppert, A. | Browning, R. | +12

10

Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia

enthalten in: Leukemia research | 2013

von Stephens, D. | Ruppert, A. | Maddocks, K. | +12

CommentIn: Leuk Res. 2013 Oct;37(10):1187-8. - PMID 23845889